Atopic dermatitis (eczema) trials in Bulgaria

In Bulgaria 9 Also abroad 251

9 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
Where
Sofia, Sofiya
Age
18 years to 64 years
People
165 worldwide
Run by
Pfizer
See details and how to joinNCT07216027 · EU 2025-522965-31-00
Phase 2Taking people
A Phase 2b Study of the Effects of Camoteskimab in Adults with Moderate-to-Severe Atopic Dermatitis
Where
Burgas, Kazanlak, Lovech, Pleven, Varna
Age
18 years and over
People
138 worldwide
Run by
Apollo Therapeutics Limited
See details and how to join2026-525673-39-00 · EU 2026-525673-39-00
Phase 3Taking people
A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis
Where
Burgas, Pleven, Sofiya
Age
12 years and over
People
510 worldwide
Run by
Nektar Therapeutics
See details and how to joinNCT07690371 · EU 2025-524925-42-00
Phase 2Not yet taking people in Bulgaria
A study to Evaluate the Efficacy and Safety of ENV-294 in Adult Participants with Moderate-to-Severe Atopic Dermatitis
Where
Burgas, Sofiya
Age
18 years and over
People
96 worldwide
Run by
Enveda Therapeutics Inc.
See details and how to join2026-526184-38-00 · EU 2026-526184-38-00
Phase 1Taking people
A Phase 1 first-in-human study to evaluate SAR447754 in healthy adult participants and in adult participants with moderate-to-severe atopic dermatitis.
Where
Sofia
Age
18 years to 64 years
People
291 worldwide
Run by
Sanofi-Aventis Recherche & Developpement
See details and how to join2025-523826-41-00 · EU 2025-523826-41-00
Phase 1Taking people
A first-in-human, dose finding study to evaluate the safety, tolerability and pharmacokinetics of EGL-003 in healthy volunteers followed by adults with autoimmune disease.
Where
Burgas, Lovech, Pleven, Plovdiv, Sofiya, Stanboliyski
Age
18 years to 64 years
People
80 worldwide
Run by
Egle Therapeutics
See details and how to join2025-521658-40-00 · EU 2025-521658-40-00
Phase 2Taking people
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
Where
Burgas, Kazanlak, Lovech, Pleven, Varna
Age
18 years to 65 years
People
280 worldwide
Run by
Apollo Therapeutics Ltd
See details and how to joinNCT07599813
Phase 1Taking people
A 3-part Study of SYX-5219 in Healthy Volunteers and Participants With Atopic Dermatitis
Where
Sofia
Age
18 years to 65 years
People
149 worldwide
Run by
Sitryx Therapeutics Ltd
See details and how to joinNCT07558668
Phase 2Taking people
Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD
Where
Lovech, Pleven, Sevlievo, Sofiya
Age
18 years and over
People
200 worldwide
Run by
Corvus Pharmaceuticals, Inc.
See details and how to joinNCT07441395 · EU 2025-524384-20-00